GSK reports strong VMS growth amid COVID-19

4 August 2020 - Deborah Wilkes

GlaxoSmithKline (GSK) Consumer Healthcare’s sales of vitamins, minerals and supplements (VMS) “continued to grow strongly” in the second quarter of 2020, according to the company.